Human Chorionic Gonadotropin Market By Treatment (Female Infertility Treatment, Oligospermia Treatment, Cryptorchidism Treatment), By Technology (Natural Source Extraction, Recombinant Dna Technology) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Fertility patterns worldwide have changed dramatically and a rise in the infertility rates have been observed since the last two decades. Even though newer assisted techniques such as in-vitro fertilization have been well developed, still fertility drugs are the first choice for treatment of infertility issues. Even in the fertility drugs category, hormonal products are preferred the most. Since the human body is governed by hormones, infertility is considered to be caused due to the abnormal play of the hormones.

This report studies the global human chorionic gonadotropin (HCG) market based on use of human chorionic gonadotropin in various treatments and production technologies. HCG is widely used for female infertility treatment, oligospermia, and cryptorchidism treatments. Based on manufacturing technologies the HCG market is categorized into natural source extraction and recombinant DNA technology. This report studies these segments in terms of their historical and future market size and forecast for the period 2014-2022. Respective compounded annual growth rates (CAGR %) for these segments for the period 2016-2022 are also presented in this study.

Geographically, the global human chorionic gonadotropin market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Rest of Asia-Pacific
  • Middle East and Africa
  • Latin America

The market size and forecast for the period 2014-2022 along with the CAGRs for the period 2016-2022 are also provided in this report.

Qualitative information such as drivers, restraints and future opportunities for the global hospital-acquired disease testing market are included in this report. Competition assessment tools such as competition analysis and attractive investment proposition are presented in this study for scrutinizing competition of the global human chorionic gonadotropin market. This study concludes with the company profiles section that highlights information about the key companies engaged in development, manufacture and provision of human chorionic gonadotropin products.

Choose License Type
Trusted By
Related Report

Published Date:  Jul 2016
Category:  Pharmaceuticals
Report ID:   57982
Report Format:   PDF
Pages:   120
Rating:    4.4 (65)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support